Adcirca
Product Images NDC 43353-070

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Adcirca (NDC 43353-070). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 20mg (43353 0070 12)

Adcirca Tadalafil is a medication available in the form of 20mg tablets. The package contains 12 tablets and is identified by the NOC# 43353007012.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Structural Formula (Adcirca Tablets 01)

FDA Label Image

Figure 1 (Adcirca Tablets 05)

FDA Label Image

Figure 2 (Adcirca Tablets 06)

This is a report of clinical trial results for a drug called ADCIRCA. It shows data related to subjects who had a disease that affects blood vessels in the lungs. The report provides demographic information about the subjects (gender, age, etc.) and some details about the baseline characteristics of the study group. It also reports the results of a test called the Six Minute Walk Distance, which measures how far a person can walk in six minutes. There is a graph that shows the change in walking distance for people who took the drug versus those who took a placebo. The report provides mean change data as well as confidence intervals.*

FDA Label Image

Figure 3 (Adcirca Tablets 07)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.